
Hundreds of children across England are set to benefit from a new drug which has been approved for rollout on the NHS to treat a severe muscle-wasting condition.
Givinostat is expected to enable eligible patients with Duchenne muscular dystrophy (DMD) to maintain their mobility for longer.